Skip to content
Research Article Open access CC BY 4.0

Assessing Pharmaceutical Equivalence of Generic Antibiotics Using in vitro Antimicrobial Susceptibility of Some Hospital Strains in Rwanda

Justin Ntokamunda Kadima, Jean Baptiste Nyandwi, Carole Inyange Kayitana, Albert Mashaku

Journal of Advances in Medicine and Medical Research · pp. 1–8 · Published 12 Apr 2016

10.9734/BJMMR/2016/25137

Abstract

The study aimed at evaluating the pharmaceutical equivalence of generic commercial products containing same common antibiotics by testing in vitro the antimicrobial susceptibility/resistance of common bacterial isolates from patients. In total 35 different generic preparations and brands corresponding to seven antibiotics- Ampicillin, Amoxicillin, Amoxicillin/clavulanic acid, Cotrimoxazole, Norfloxacin, and Erythromycin- were compared by a disc diffusion method against three pathogenic strains- Salmonella typhi, Shigella flexneri and Staphylococcus aureus- isolated from patients. Some brands were presumptively regarded as good quality medicines to serve as gold standards instead of using international references. The pharmaceutical quality of the preparations was checked by visual inspection and identification of active ingredients according to referral pharmacopeias. All products satisfied visual inspection and identification tests. However they exhibited differences in their antimicrobial profiles and potency. Two generic preparations containing amoxicillin/clavulanic acid were out of specifications (<90%) as compared with Augmentin® gold standard. Comparing the susceptibility of bacteria by the diameter (d) of inhibition zone in mm, Salmonella typhi was susceptible to Norfloxacin (d=23.2), low to Augmentin (d=11.5), and resistant to Ampicillin, Amoxicillin, Cotrimoxazole and Erythromycin (d=0). Shigella flexneri was susceptible to all antibiotics (d=31.6 – 42.8) except Erythromycin (d=0) which exhibited the lowest spectrum of activity. Staphylococcus aureus was susceptible to all antibiotics with different potencies (d=20 for Amoxicillin – d=42.6 for Norfloxacin). These findings showed the possibility of using a simple in vitro antimicrobial susceptibility testing to compare the equivalence of marketing antibiotic products in quality and efficacy. The result also could help clinicians choosing the most appropriate antibiotic in treatment.

Antimicrobial susceptibility resistance Shigella Staphylococcus Salmonella antibiotics

References (18)

  1. 1 Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications [DOI]
  2. 2 Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda [DOI]
  3. 3 Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence [DOI]
  4. 4 Growing Problem of Multidrug-Resistant Enteric Pathogens in Africa [DOI]
  5. 5 High Prevalence of Antimicrobial Resistance Among Common Bacterial Isolates in a Tertiary Healthcare Facility in Rwanda [DOI]
  6. 6 A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better? [DOI]
  7. 7 Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics [DOI]
  8. 8 Antimicrobial Susceptibility Patterns of Shigella Isolates in Foodborne Diseases Active Surveillance Network (FoodNet) Sites, 2000–2010 [DOI]
  9. 9 Epidemiology and surveillance of antimicrobial resistance in the tropics [DOI]
  10. 10 In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn®, Wyeth) formulation [DOI]
  11. 11 Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): Increasing frequency of multiple resistance [DOI]
  12. 12 Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products of vancomycin [DOI]
  13. 13 Antibiotic Resistance ofSalmonella entericaSerovar Typhi in Kolkata, India, andIn VitroExperiments on Effect of Combined Chemotherapy [DOI]
  14. 14 [Norfloxacin: more than 20 years of clinical use, the results and place among fluoroquinolones in modern chemotherapy for infections].
  15. 15 Analytical Tools and Strategic Approach to Detect Poor Quality Medicines, Identify Unknown Components, and Timely Alerts for Appropriate Measures: Case Study of Antimalarial Medicines [DOI]
  16. 16 [3-year study of shigellosis epidemic in Rwanda, Central Africa. Problems of public health and bacteriological aspects].
  17. 17 [Shigella and Salmonella isolated in Burundi from 1980 to 1985].
  18. 18 [Antibiotic sensitivity of 299 strains of shigella isolated in Burundi].

Cited by 3

Antibiogram Profile of Antibacterial Multidrug Resistance in Democratic Republic of Congo: Situation in Bukavu City Hospitals

Justin Ntokamunda Kadima, Christian Ahadi Irenge, Patient Birindwa Mulashe · 2021

Profile of Multidrug Resistant Bacteria in Bukavu Hospitals and Antimicrobial Susceptibility to <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i>, <i>Proteus mirabilis and Staphylococcus aureus</i>

Christian Ahadi Irenge, Freddy Bikioli, Patient Birindwa Mulashe · Advances in Microbiology · 2024

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

38

Page views

0

PDF downloads

5

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.